AIM ImmunoTech (AIM) Preferred Shares (2019 - 2024)
AIM ImmunoTech's (AIM) quarterly Preferred Shares came in at $689000.0 in Q1 2024, little changed YoY from $692000.0 in Q2 2023, and little changed on a QoQ basis from $689000.0 in Q4 2023.
AIM ImmunoTech (AIM) Preferred Shares (2019 - 2024) Analysis & Trends
AIM ImmunoTech (AIM) has 6 years of Preferred Shares data on file, last reported at $689000.0 in Q1 2024.
- Quarterly Preferred Shares changed 0.43% year-over-year to $689000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $689000.0 (changed 0.43% YoY) and the FY2023 annual result came in at $689000.0, down 1.01% from the prior year.
- Preferred Shares steadied at $689000.0 in Q1 2024, from $689000.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $769000.0 in Q1 2020 to a low of $689000.0 in Q4 2023.
- A 5-year average of $714588.2 and a median of $715000.0 in 2021 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 73600.0% in 2020, down 69.47% in 2020.
- Tracing AIM's Preferred Shares over 5 years: stood at $732000.0 in 2020, then retreated by 2.32% to $715000.0 in 2021, then fell by 2.66% to $696000.0 in 2022, then fell by 1.01% to $689000.0 in 2023, then changed by 0.0% to $689000.0 in 2024.
- The last three Preferred Shares figures came in at $689000.0 (Q1 2024), $689000.0 (Q4 2023), and $690000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | AIM ImmunoTech | 4.45 Mn | -5.52 Mn | 21,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | 689,000.00 |
| Sep 30, 2023 | 690,000.00 |
| Jun 30, 2023 | 690,000.00 |
| Mar 31, 2023 | 692,000.00 |
| Dec 31, 2022 | 696,000.00 |
| Sep 30, 2022 | 713,000.00 |
| Jun 30, 2022 | 713,000.00 |
| Mar 31, 2022 | 715,000.00 |
| Dec 31, 2021 | 715,000.00 |
| Sep 30, 2021 | 725,000.00 |
| Jun 30, 2021 | 725,000.00 |
| Mar 31, 2021 | 725,000.00 |
| Dec 31, 2020 | 732,000.00 |
| Sep 30, 2020 | 733,000.00 |
| Jun 30, 2020 | 737,000.00 |
| Mar 31, 2020 | 769,000.00 |
| Dec 31, 2019 | 778,000.00 |
| Sep 30, 2019 | 783,000.00 |
| Jun 30, 2019 | 1,000.00 |